Direct visualization of the human estrogen receptor reveals a role for ligand in the nuclear distribution of the receptor

Molecular Biology of the Cell

Volumn 10, Issue 2, 1999, Pages 471-486

  Htun, Han ^a,c   Holth, Laurel T ^b   Walker, Dawn ^a   Davie, James R ^b   Hager, Gordon L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; FULVESTRANT; GREEN FLUORESCENT PROTEIN; LIGAND; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CYTOPLASM; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

EID: 0032919564     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.2.471     Document Type: Article

References (67)

1. Alexander, R.B., Greene, G.L., and Barrack, E.R. (1987). Estrogen receptors in the nuclear matrix: direct demonstration using monoclonal antireceptor antibody. Endocrinology 120, 1851-1857.
2. Allegra, J.C., Barlock, A., Huff, K.K., and Lippman, M.E. (1980). Changes in multiple or sequential estrogen receptor determinations in breast cancer. Cancer 45, 792-794.
3. Barrack, E.R., and Coffey, D.S. (1980). The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J. Biol. Chem. 255, 7265-7275.
4. Beato, M., Chavez, S., and Truss, M. (1996). Transcriptional regulation by steroid hormones. Steroids 61, 240-251.
5. Belgrader, P., Siegel, A.J., and Berezney, R. (1991). A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix. J. Cell Sci. 98, 281-291.
6. Berezney, R. (1991). The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus. J. Cell. Biochem. 47, 109-123.
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
8. Brzozowski, A.M., Pike, A.C., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
9. Carey, K.L., Richards, S.A., Lounsbury, K.M., and Macara, I.G. (1996). Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the Ran/TC4 GTPase mediates an essential function independent of nuclear protein import. J. Cell Biol. 133, 985-996.
10. Chase, W., and Bown, F. (1992). General Statistics, 2nd ed., New York: John Wiley & Sons.
11. Danielian, P.S., White, R., Lees, J.A., and Parker, M.G. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025-1033.
12. Dauvois, S., White, R., and Parker, M.G. (1993). The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 106, 1377-1388.
13. Davie, J.R. (1995). The nuclear matrix and the regulation of chromatin organization and function. Int. Rev. Cytol. 162A, 191-250.
14. Davie, J.R., Samuel, S., Spencer, V., Bajno, L., Sun, J.-M., Chen, H.Y., and Holth, LT. (1997). Nuclear matrix: application to diagnosis of cancer and role in transcription and modulation of chromatin structure. Gene Ther. Mol. Biol. 1, 509-528.
15. DeFranco, D.B., Madan, A.P., Tang, Y., Chandran, U.R., Xiao, N., and Yang, J. (1995). Nucleocytoplasmic shuttling of steroid receptors. Vitam. Horm. 51, 315-338.
16. Gallo, M.A., and Kaufman, D. (1997). Antagonistic and agonistic effects of tamoxifen: significance in human cancer. Semin. Oncol. 24, S1-71-S1-80.
17. Garcia, M., Derocq, D., Freiss, G., and Rochefort, H. (1992). Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. USA 89, 11538-11542.
18. Gorski, J., Toft, D., Shyamala, G., Smith, D., and Notides, A. (1968). Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog. Horm. Res. 24, 45-80.
19. Greene, G.L., and Press, M.F. (1986). Structure and dynamics of the estrogen receptor. J. Steroid Biochem. 24, 1-7.
20. Hou, Q., Paria, B.C., Mui, C., Dey, S.K., and Gorski, J. (1996). Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation. Proc. Natl. Acad. Sci. USA 93, 2376-2381.
21. Htun, H., Barsony, J., Renyi, I., Gould, D.L., and Hager, G.L. (1996). Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 93, 4845-4850.
22. Jackson, D.A., and Cook, P.R. (1988). Visualization of a filamentous nucleoskeleton with a 23 nm axial repeat. EMBO J. 7, 3667-3677.
23. Jensen, E.V. (1991). Overview of the nuclear receptor family. In: Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities, ed. M.G. Parker, San Diego: Academic Press, 1-13.
24. Jensen, E.V., Suzuki, T., Kawashima, T., Stumpf, W.E., Jungblut, P.W., and DeSombre, E.R. (1968). A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. USA 59, 632-638.
25. Jiang, S.Y., and Jordan, V.C. (1992). Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst. 84, 580-591.
26. King, W.J., and Greene, G.L. (1984). Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307, 745-747.
27. Kingston, R.E., Chen, C.A., and Okayama, H. (1995). Introduction of DNA into mammalian cells. In: Current Protocols in Molecular Biology, chap. 9, ed. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, New York: John Wiley & Sons.
28. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J.A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
29. Kumar, V., and Chambon, P. (1988). The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55, 145-156.
30. Lavinsky, R.M., et al. (1998). Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95, 2920-2925.
31. Levenson, A.S., and Jordan, V.C. (1994). Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J. Steroid Biochem. Mol. Biol. 51, 229-239.
32. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., and Chambon, P. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
33. Martinez, E., and Wahli, W. (1989). Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 8, 3781-3791.
34. McDonnell, D.P., Clemm, D.L., Hermann, T., Goldman, M.E., and Pike, J.W. (1995). Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9, 659-669.
35. McDonnell, D.P., Clemm, D.L., and Imhof, M.O. (1994). Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Semin. Cancer Biol. 5, 327-336.
36. McDonnell, D.P., Nawaz, Z., and O'Malley, B.W. (1991). In situ distinction between steroid receptor binding and transactivation at a target gene. Mol. Cell. Biol. 11, 4350-4355.
37. McDonnell, D.P., Vegeto, E., and O'Malley, B.W. (1992). Identification of a negative regulatory function for steroid receptors. Proc. Natl. Acad. Sci. USA 89, 10563-10567.
38. Mymryk, J.S., and Archer, T.K. (1995). Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes & Dev. 9, 1366-1376.
39. Ogawa, H., Inouye, S., Tsuji, F.I., Yasuda, K., and Umesono, K. (1995). Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc. Natl. Acad. Sci. USA 92, 11899-11911.
40. Parker, M.G. (1992). Introduction. In: Growth Regulation by Nuclear Hormone Receptors, ed. M.G. Parker, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1-4.
41. Pham, T.A., Elliston, J.F., Nawaz, Z., McDonnell, D.P., Tsai, M.J., and O'Malley, B.W. (1991a). Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. USA 88, 3125-3129.
42. Pham, T.A., Hwung, Y.P., McDonnell, D.P., and O'Malley, B.W. (1991b). Transactivation functions facilitate the disruption of chromatin structure by estrogen receptor derivatives in vivo. J. Biol. Chem. 266, 18179-18187.
43. Picard, D., Kumar, V., Chambon, P., and Yamamoto, K.R. (1990). Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul. 1, 291-299.
44. Pratt, W.B., and Toft, D.O. (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306-360.
45. Press, M.F., Nousek-Goebl, N.A., and Greene, G.L. (1985). Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J. Histochem. Cytochem. 33, 915-924.
46. Press, M.F., Xu, S.H., Wang, J.D., and Greene, G.L. (1989). Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Am. J. Pathol. 135, 857-864.
47. Rizzuto, R., Brini, M., De Giorgi, F., Rossi, R., Heim, R., Tsien, R.Y., and Pozzan, T. (1996). Double labeling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr. Biol. 6, 183-188.
48. Sabbah, M., Gouilleux, F., Sola, B., Redeuilh, G., and Baulieu, E.E. (1991). Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. Proc. Natl. Acad. Sci. USA 88, 390-394.
49. Samaan, N.A., Buzdar, A.U., Aldinger, K.A., Schultz, P.N., Yang, K.P., Romsdahl, M.M., and Martin, R. (1981). Estrogen receptor: a prognostic factor in breast cancer. Cancer 47, 554-560.
50. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
51. Samuel, S.K., Spencer, V.A., Bajno, L., Sun, J.-M., Holth, L.T., Oesterreich, S., and Davie, J.R. (1998). In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells. Cancer Res. (in press).
52. Seiler-Tuyns, A., Walker, P., Martinez, E., Merillat, A.M., Givel, F., and Wahli, W. (1986). Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. Nucleic Acids Res. 14, 8755-8770.
53. Shibata, H., Spencer, I.E., Onate, S.A., Jenster, G., Tsai, S.Y., Tsai, M.J., and O'Malley, B.W. (1997). Role of coactivators and corepressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52, 141-165.
54. Smith, C.L., Nawaz, Z., and O'Malley, B.W. (1997). Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11, 657-666.
55. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., and Chambon, P. (1989). The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8, 1981-1986.
56. Tsai, M.J., and O'Malley, B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
57. Vazquez-Nin, G.H., Echeverria, O.M., Fakan, S., Traish, A.M., Wotiz, H.H., and Martin, T.E. (1991). Immunoelectron microscopic localization of estrogen receptor on premRNA containing constituents of rat uterine cell nuclei. Exp. Cell Res. 192, 396-404.
58. Vegeto, E., Wagner, B.L., Imhof, M.O., and McDonnell, D.P. (1996). The molecular pharmacology of ovarian steroid receptors. Vitam. Horm. 52, 99-128.
59. Wakeling, A.E., Dukes, M., and Bowler, J. (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res. 51, 3867-3873.
60. Welshons, W.V., Cormier, E.M., Wolf, M.F., Williams, P.O., Jr., and Jordan, V.C. (1988). Estrogen receptor distribution in enucleated breast cancer cell lines. Endocrinology 122, 2379-2386.
61. Welshons, W.V., Lieberman, M.E., and Gorski, J. (1984). Nuclear localization of unoccupied oestrogen receptors. Nature 307, 747-749.
62. Wijnholds, J., Philipsen, J.N., and Ab, G. (1988). Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo. EMBO J. 7, 2757-2763.
63. Williams, M.R., Todd, J.H., Ellis, I.O., Dowle, C.S., Haybittle, J.L., Elston, C.W., Nicholson, R.I., Griffiths, K., and Blarney, R.W. (1987). Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br. J. Cancer 55, 67-73.
64. Yamashita, S. (1995). Intranuclear localization of hormone-occupied and -unoccupied estrogen receptors in the mouse uterus: application of 1 nm immunogold-silver enhancement procedure to ultrathin frozen sections. J. Electron Microsc. 44, 22-29.
65. Yee, D., McGuire, S.E., Brunner, N., Kozelsky, T.W., Allred, D.C., Chen, S.H., and Woo, S.L. (1996). Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther. 7, 1251-1257.
66. Zajchowski, D.A., Sager, R., and Webster, L. (1993). Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 53, 5004-5011.
67. Zhang, X., Jeyakumar, M., Petukhov, S., and Bagchi, M.K. (1998). A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12, 513-524.